Masaaki Kondo
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 17, 2019
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial.Masaaki Kondo, Manabu Morimoto, Satoshi Kobayashi
|Jun 01, 2018
Activation of Signal Transduction and Activator of Transcription 3 Signaling Contributes to Helicobacter-Associated Gastric Epithelial Proliferation and Inflammation.Yasuaki Ishii, Wataru Shibata, Makoto Sugimori
|May 17, 2018
Response to: Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin".Soichiro Sue, Nobumi Suzuki, Wataru Shibata
|Apr 20, 2018
Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial.Yasuaki Ishii, Hiroaki Yamada, Takeshi Sato
|Nov 29, 2017
First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin.Soichiro Sue, Nobumi Suzuki, Wataru Shibata
|Jul 19, 2017
Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression.Masaaki Kondo, Kazushi Numata, Koji Hara
Pageof 1
